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Malignant glomus tumor, or glomangiosarcoma, is a very rare mesenchymal neoplasm that, when seen, occurs in
visceral organs. Despite having histologic features of malignancy, these tumors usually do not metastasize.
However, when metastasis occurs, this disease is often fatal. Our report presents the case of a 59-year-old female
patient with a highly aggressive and widely metastatic glomus tumor of the lung.
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Glomus tumors are uncommon benign neoplasms that
customarily originate from glomus bodies in the dermis
or subcutis of the extremities. Extracutaneous glomus
tumors occur but are very rare, especially in visceral
organs such as the stomach, mediastinum, trachea, lung,
ileum, and kidney [1-5]. A few cases of glomangiosar-
coma in visceral organs have been reported; neverthe-
less, these all involved local invasion and metastasis
occurred scarcely [6]. Herein, we report a case with a
highly aggressive and widely metastatic malignant glomus
tumor of the lung.Case presentation
A 59-year-old female patient (living in eastern China, at
an altitude of 550 m) presented to our hospital com-
plaining of an ongoing cough and hemoptysis for
4 months and melena for 1 week. The patient’s medical
history was unremarkable. The auscultation revealed
attenuated respiratory sound in bilateral lungs and no
rales or wheezing were noted. There was no superficial
node enlargement. Laboratory investigations showed
normocytic anemia (hemoglobin level 58 g/L) and a
platelet count of 294 × 109 /L. The computed tomog-
raphy (CT) scan of the chest showed multiple masses in
bilateral lungs with the largest measuring 25 mm in
diameter in the left upper lobe (Figure 1A,B) and an* Correspondence: wsaibin@126.com
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unless otherwise stated.irregularly protruding edge, lobulated mass was abutting
the left cardiac border in the left inferior lobe (Figure 1D–E).
Also noted were mildly enlarged mediastinal nodes.
Enhanced CT scans of the abdomen demonstrated
gastrointestinal lumen multiple clumps, with the upper
right jejunum intussusception, incomplete obstruction
by tumor, and multiple mass in spleen and ileum
considering tumor metastasis (Figure 1F–H). To make a
definite diagnosis of tumor, an endoscopic study was
performed. Bronchoscopy revealed new features in the
left lung lingual lobe cavity, the lumen was completely
blocked. Gastroscopy revealed stomach multiple clumps.
Pathology and immunohistochemistry were subsequently
performed. Immunohistochemically, tumor cells from
the lung were positive for SMA (Figure 2A), CD163,
F8, vimentin (Figure 2E), and collagen IV (Figure 2C),
whereas they were negative for CD21, CD31, CD34,
CD35, CD117, Bcl-2, CK7, CKlow, EMA, HMB45, desmin,
myosin, s-100, and TTF-1 (Table 1). Tumor cells from
stomach were positive for SMA (Figure 2B) and collagen
IV (Figure 2D), and F8 was rare weakly positive, whereas
they were negative for CD31, CD117, CK, dog-1, HMB45,
desmin, and s-100. Ki-67 labeling index reached about
60% (Figure 2F) from lung specimen and about 40% from
stomach (Table 1). The histopathological findings were
consistent with malignant glomus tumor [7]. With deteri-
orating medical conditions and widespread metastasis, the
patient was submitted to a palliative therapy. Bronchial
artery embolization was given for hemostasis. The patient
developed more generalized weakness and eventually died
within 20 weeks of diagnosis.This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 CT scans. (A, B) multiple mass in bilateral lungs; (C–E) the lobulated glomangiosarcoma was abutting the left cardiac border in the left
inferior lobe; (F–H) multiple metastasis: to stomach and spleen (F), to jejunum (G), to ileum (H) (arrows).
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Glomus tumors typically present as solitary or multi-
centric lesions in the dermis or subcutis, with character-
istic subungual location. Extracutaneous presentations
occur but are rare, especially in the visceral organs,
where glomus bodies are sparse or even absent, includ-
ing the respiratory tract, gastrointestinal tract, and medi-
astinum. Within the respiratory tract, the trachea is
the most frequent site of involvement. Primary glomus
tumors of the lung, especially with metastasis, are
extremely rare. To the best of our knowledge, only three
cases have been reported in the English literature. The
first case of a glomangiomyoma of the lung with wide-
spread metastasis was reported by Gaertner et al. [8] in
2000, in which the patient developed widespread meta-
static disease to the lungs, upper mediastinum, brain,
liver, and subcutaneous tissue of the lower limb after
surgery, then she received chemotherapy and ultimately
died 68 weeks after surgery. A decade later, Liu et al. [9]
reported another case of primary malignant glomusFigure 2 Immunohistochemical staining. SMA was expressed strongly b
expressed weakly by tumor cells from lung (C) and strongly from stomach
positive expression is about 60% by tumor cells from lung (F).tumor in the lung with multiple metastasis to the left
lung, visceral pleura, adjacent bronchi, and the vessel
walls. The patient also underwent surgery and chemo-
therapy, but died 4 days after surgery due to pulmonary
failure. This was followed by Hohenforst-Schmidt et al.
[10], who reported a case of glomus tumor in the left
hilum of the lung, but multiple lung metastasis were
evident at the 6-year follow-up visit; the patient was
submitted to a pneumonectomy of the left lung and was
disease free within in the surgical limits.
Folpe et al. [7] proposed the following criteria for ma-
lignant glomus tumor: tumors with a deep location and
a size of more than 20 mm, or atypical mitotic figures,
or moderate to high nuclear grade and ≥5 mitotic figures
per 50 high power fields. In our case, the diameter of
the largest mass was 25 mm in the left upper lobe
(Figure 1A). Microscopically, nuclear atypia of tumor
cells with high mitotic activity was evident (Figure 3),
fulfilling the criteria for malignancy. Given the rarity of
reported cases of malignant glomus tumor of the lung,y tumor cells from lung (A) and from stomach (B); type IV collagen
(D); vimentin positive expression by tumor cells from lung (E); Ki-67
Figure 3 Microscopic appearance (H&E). Histocytologic features of glom
Cytological atypia and increased mitotic activity was observed from lung (B
Table 1 Immunohistochemical characteristics of the
tumor cells
Antibodies to Tumor cells from lung Tumor cells from stomach
EMA Negative Not done
SMA Positive Positive
Actin Rare weakly positive Not done
Vimentin Positive Not done
CD a1 Negative Not done
CD 21 Negative Not done
CD 31 Negative Negative
CD 34 Negative Not done
CD 35 Negative Not done
CD 99 Rare weakly positive Not done
CD 117 Negative Negative
CD 163 Positive Not done
F8 Positive Rare weakly positive
Dog-1 Not done Negative
HMB 45 Negative Negative
S-100 Negative Negative
Desmin Negative Negative
Collagen IV Rare weakly positive Positive
Bcl-2 Negative Not done
CK Not done Negative
CK 7 Negative Not done
CK low Negative Not done
Myosin Negative Not done
TTF-1 Negative Not done
Ki-67 labeling index About 60% About 40%
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monary disorders. Malignant glomus tumors have to be
differentiated from other lesions such as Ewing’s tumors/
primitive neurectodermal tumors, carcinoid tumors, neuro-
endocrine carcinoma, sclerosing hemangioma, malignant
melanoma, synovial sarcoma, malignant mesothelioma,
hemangiopericytoma, and metastatic tumors. Histologic
and immunohistochemical features are fundamental in
establishing the diagnosis of malignant glomus tumors,
the clinicopathologic features and immunohistochemi-
cal profiles of which were summarized initially by
Khoury et al. [11]. In this case, it was slightly difficult to
differentiate from a multiple gastrointestinal glomus
tumor with lung metastasis; however, the possibility of
metastatic malignant glomus tumors from other organs
to the lung was obviated in light of the clinical and
radiological evidence. The patient was referred to hos-
pital due to long term pulmonary symptoms rather than
gastrointestinal discomfort. However, and even more
importantly, the irregularly protruding edge, lobulated
mass in the left inferior lobe (Figure 1D–E), considered
a primary lesion, did not meet the characteristics of
metastasis in radiology.
Surgical resection is curative and remains the mainstay
of treatment in reported cases of malignant glomus
tumor diagnosed with or without local metastasis [2],
and long term follow-up is greatly recommended. Milia
et al. [12] reported a successful outcome with combined
radiotherapy and chemotherapy in a case of malignant
glomus tumor in a 40-year-old man presenting with a le-
sion in the upper cervical region. In our case, the patient
lost the opportunity for surgery given the widespreadangiosarcoma from lung (A, ×200) and from stomach (C, ×200).
, ×400) and from stomach (D, ×400).
Table 2 Cases of primary pulmonary glomus tumors with metastasis
Case Sex /Age
(years)
Symptoms Site Metastatic sites Treatment Follow-up
Gaertner et al. [8] M/69 Hemoptysis RUL Lungs, mediastinum,
brain, liver, lower limb
Lobectomy,
chemotherapy
DOD at 68 weeks




Left lung, visceral pleura,
the vessel walls, bronchi
Lobectomy,
chemotherapy
DOD at 4 days
Hohenforst-Schmidt
et al. [10]
F/35 Thoracic pain LHL Left lung Lobectomy FOD in surgical limits,
N/A
Wang et al. F/59 Cough, hemoptysis,
melena
LIL Lungs, stomach, jejunum,
ileum, mediastinal nodes
Palliative therapy DOD at 20 weeks
RUL, Right upper lobe; LUL, Left upper lobe; LIL, Left inferior lobe; LHL, Left hilum of the lung; FOD, Free of disease; N/A, Not available.
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therapy because of asthenia, resulting in fatality.
Conclusions
Malignant glomus tumor of the lung, particularly with
multiple metastasis, is exceedingly rare. The cornerstone
of diagnosis is pathological features and immunostaining.
This case, combined with the other three cases mentioned
above (Table 2), indicate that a case of malignant glomus
tumor with widespread metastasis is often fatal. Diagnosis
before metastasis and effortlessly aggressive surgical treat-
ment is essential of excellent prognosis in this disease.
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